CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Total Assets (Quarterly) : 19.05M for Aug. 31, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 19.05M |
| May 31, 2026 | 13.97M |
| February 28, 2026 | 18.50M |
| November 30, 2025 | 8.935M |
| August 31, 2025 | 13.48M |
| May 31, 2025 | 18.05M |
| February 28, 2025 | 21.19M |
| November 30, 2024 | 24.88M |
| August 31, 2024 | 28.02M |
| May 31, 2024 | 11.14M |
| February 29, 2024 | 10.27M |
| November 30, 2023 | 9.24M |
| August 31, 2023 | 12.41M |
| May 31, 2023 | 11.29M |
| February 28, 2023 | 14.64M |
| November 30, 2022 | 7.074M |
| August 31, 2022 | 28.39M |
| May 31, 2022 | 29.18M |
| February 28, 2022 | 94.08M |
| November 30, 2021 | 103.70M |
| August 31, 2021 | 104.97M |
| May 31, 2021 | 132.08M |
| February 28, 2021 | 113.65M |
| November 30, 2020 | 143.76M |
| August 31, 2020 | 93.36M |
| Date | Value |
|---|---|
| May 31, 2020 | 50.51M |
| February 29, 2020 | 38.82M |
| November 30, 2019 | 17.92M |
| August 31, 2019 | 18.39M |
| May 31, 2019 | 20.87M |
| February 28, 2019 | 20.43M |
| November 30, 2018 | 20.39M |
| August 31, 2018 | 9.031M |
| May 31, 2018 | 4.899M |
| February 28, 2018 | 8.284M |
| November 30, 2017 | 6.491M |
| August 31, 2017 | 6.128M |
| May 31, 2017 | 8.055M |
| February 28, 2017 | 14.76M |
| November 30, 2016 | 15.67M |
| August 31, 2016 | 9.293M |
| May 31, 2016 | 13.79M |
| February 29, 2016 | 14.59M |
| November 30, 2015 | 6.561M |
| August 31, 2015 | 6.139M |
| May 31, 2015 | 4.679M |
| February 28, 2015 | 4.675M |
| November 30, 2014 | 5.664M |
| August 31, 2014 | 5.586M |
| May 31, 2014 | 8.427M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 117.13M |
| Shareholders Equity (Quarterly) | -98.07M |
| Debt to Equity Ratio | -0.2781 |
| Current Ratio | 0.382 |
| Net Debt Paydown Yield | 0.00% |